@prefix this: . @prefix sub: . @prefix np: . @prefix rdf: . @prefix xsd: . @prefix rdfs: . @prefix ns2: . @prefix ns1: . @prefix prov: . @prefix ns3: . @prefix npx: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubInfo; a np:Nanopublication . } sub:assertion { ns1:interact . } sub:provenance { sub:assertion prov:generatedAtTime "2021-12-16T20:05:38.768563"^^xsd:dateTime; prov:wasGeneratedBy "S&T TWOC project version 2" . sub:version prov:value "2"^^xsd:integer . rdf:OBJECT rdfs:label "with both the catalytic residues of SARS CoV-2 Mpro , a key component of viral replication ( His41 and Cys145 )" . rdf:OBJECT-POSITION rdfs:label "59"^^xsd:integer . rdf:PREDICATE rdfs:label "interacted" . rdf:PREDICATE-POSITION rdfs:label "[46]" . rdf:SUBJECT rdfs:label "( betamethasone and dexamethasone )" . rdf:SUBJECT-POSITION rdfs:label "19"^^xsd:integer . rdfs:ABSTRACT-UID ns3:50 "8m75indk" . rdfs:SENTENCE rdfs:label "Two of them (betamethasone and dexamethasone) interacted with both the catalytic residues of SARS CoV-2 Mpro, a key component of viral replication (His41 and Cys145)." . rdfs:TRIPLE-UID ns2:8m75indk-TRIPLE-ABSTRACT-15 "8m75indk-TRIPLE-ABSTRACT-15" . rdfs:label "dexamethasone" . rdfs:label "component" . } sub:pubInfo { sub:assertion prov:wasDerivedFrom . sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB"; npx:hasSignature "cE76p7ezGYVee2ZIoh+9TmCIKR4MnrPuoqA1440nSQIaLbaD2g//PqA91UFYHji7FRcd5c34QM+mFFGxRl8RQV0R/8uyWiUJ1WX6y8fxa+wf4+uqwLvDp0CRlOY8cQB/VB8rOtF/SuIhwH01isvHeT3ZWWvYJdBqPwaOU9Yg2po="; npx:hasSignatureTarget this: . this: prov:generatedAtTime "2021-12-16T20:05:38.768563"^^xsd:dateTime; prov:wasAttributedTo . }